Volume 29, Number 2—February 2023
Synopsis
Streptococcus dysgalactiae Bloodstream Infections, Norway, 1999–2021
Figure 1

Figure 1. β-hemolytic streptococcal bloodstream infections caused by Streptococcus pyogenes, S. agalactiae, and S. dysgalactiae, western Norway, 1999–2021. We calculated incidence rates for β-hemolytic streptococcal bloodstream infections in Health Region Bergen, Bergen, Norway, in 3-year periods, except 2020–2021. We calculated incidence rates as the total number of cases during each time period, divided by the number of years in the period.
Page created: December 07, 2022
Page updated: January 21, 2023
Page reviewed: January 21, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.